Navigation Links
Pharmaceuticals: Global Industry Guide
Date:1/8/2013

98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2011 162Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2011 164Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in China, 2011 165Figure 101: Netherlands pharmaceuticals market value: $ million, 2007–11 169Figure 102: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2011 170Figure 103: Netherlands pharmaceuticals market share: % share, by value, 2011 171Figure 104: Netherlands pharmaceuticals market value forecast: $ million, 2011–16 172Figure 105: Forces driving competition in the pharmaceuticals market in the Netherlands, 2011 173Figure 106: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2011 174Figure 107: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2011 176Figure 108: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2011 177Figure 109: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2011 179Figure 110: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2011 180Figure 111: Spain pharmaceuticals market value: $ billion, 2007–11 184Figure 112: Spain pharmaceuticals market geography segmentation: % share, by value, 2011 185Figure 113: Spain pharmaceuticals market share: % share, by value, 2011 186Figure 114: Spain pharmaceuticals market value forecast: $ billion, 2011–16 187Figure 115: Forces driving competition in the pharmaceuticals market in Spain, 2011 188Figure 116: Drivers of buyer power in the pharmaceuticals market in Spain, 2011 189Figure 117: Drivers of supplier power in the pharmaceuticals market in Spain, 2011 191Figure 118: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2011 192Figure 119: Factors influencing th
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Reliance Pharmaceuticals: Biosimilars Company Analysis
2. Pharmaceuticals: Global Industry Almanac, MarketLine
3. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
4. Global Biosimilars: A return to optimism?
5. Global Bariatric (Obesity) Surgical Devices Industry
6. Global Digital Radiography Industry
7. Global Market for Industrial and Institutional Cleaning Products to Exceed $52 Billion by 2018, Hand Sanitizers Poised to Reach $226.3 Million by 2018
8. CAHG Wins Global Award for Third Consecutive Year
9. Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
10. Global Market for Radiation Therapy Equipment to Reach $6.8 Billion by 2018
11. Global Market for Laboratory Glassware and Plasticware to Reach $6.16 Billion by 2018, Pipettes and Pipettors Market $1.1 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... July 1, 2015 Rock Creek Pharmaceuticals, Inc., ... on chronic inflammatory disease and neurologic disorders, announced today ... with anatabine citrate, the Company,s lead compound. Results from ... anatabine citrate can significantly inhibit the activation of inflammatory ... is developing this compound in a Phase 1 clinical ...
(Date:7/1/2015)... SAN FRANCISCO , July 1, 2015 ... a new study Stationary Oxygen Concentrators Market ... markets are poised to achieve continuing growth as the ... develop COPD and other respiratory conditions where oxygen is ... a dramatic manner. Portable devices have become affordable and ...
(Date:7/1/2015)... DIEGO , July 1, 2015 OncoSec Medical ... intratumoral cancer immunotherapies, today announced that CEO and President ... celebration of the Company,s listing to The Nasdaq Stock Market ... Nasdaq MarketSite in New York City . ... employees, investors, and stakeholders, we are honored to open the ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 2OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 3
... releases of Elekta,s XiO® treatment planning system and Focal ... and deliver radiation therapy plans more efficiently. ... Therapy (IMRT) segmentation algorithm, fluence map smoothing and DICOM ... for contouring, enabling clinicians to contour anatomy faster and ...
... the vaccines division of Sanofi (EURONEXT: SAN and NYSE: ... 2011-2012 Fluzone® Influenza Virus Vaccine in the U.S. This shipment ... influenza vaccine the company plans to deliver to the U.S. ... producer of influenza vaccine in the U.S., supplying more than ...
Cached Medicine Technology:Latest Releases of Elekta's XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer 2Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 2Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 3Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 4Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 5Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 6
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... technology and services, today announced that its fifth annual Smile for a Lifetime ... $80,000 for the non-profit organization. In addition to supporting S4L in its mission ...
(Date:7/1/2015)... ... July 01, 2015 , ... DIC Corporation today ... Linablue®, Spirulina-derived natural blue food coloring. Construction of the plant, which is located ... production base, began in May 2014. After commissioning, commercial production is expected to ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... The Collaborative ... the New York Community Trust. The grant will allow CCF to improve quality of ... practices. , CCF was formed to respond to many changes in New York’s Medicaid ...
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® ... Hospital Corporation of America (HCA), as it further expands its Strategic Alliance Partnership ... , With this new partnership, OncLive’s editorial and marketing teams will collaborate with ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... training leaders Lora Posey (Manager, National Sales Training and Development) and Chuck Corso ... Network (LTEN) Conference in Phoenix, AZ. LTEN brings together learning and development professionals ...
Breaking Medicine News(10 mins):Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4
... ABAX ), a medical products company manufacturing point-of-care blood,analysis ... 2008. , , Highlights for the third quarter ... $27.0 million, up 5% over last year,s comparable quarter., ... over last year,s, comparable quarter., ...
... underlying trait, but connection is vague, study says , , ... doesn,t decrease a woman,s risk of preterm birth, according ... a link. , As a result of those earlier ... pregnant women undergo dental "deep cleaning" (scaling and root ...
... and PALO ALTO, Calif., Jan. 29 ,Diagnosoft, Inc., ... that assists in diagnosis, staging and therapeutic monitoring ... $4 million in Series B,financing led by Technology ... intends to use the new capital to support ...
... 29 Mylan Inc. (Nasdaq: MYL ) today ... issuance, the company has declared its quarterly dividend of $16.25 ... and a liquidation preference of $1,000.00 per share) payable on ... as of Feb. 1, 2009.Mylan Inc., which provides products to ...
... Meditation Center of Los Angeles will present a program featuring ... an ancient practice of physical fitness, which has been used ... youthfulness in the body. The Level 1 & 2 ... Center for the Arts in Eagle Rock.The healing Taoist practice ...
... On February 19, 2009 at Noon CT, compliance and ... and Catholic Healthcare West will be discussing how companies ... stagnant or declining budgets. They will be participating ... and Ethics, Five Leaders, Five Industries, Ideas for Your ...
Cached Medicine News:Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 2Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 3Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 4Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 5Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 6Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 7Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 8Health News:Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 9Health News:Gum Disease Treatment Doesn't Cut Preterm Birth Risk 2Health News:Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO 2Health News:Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO 3Health News:Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO 4Health News:World-renowned Instructor of the Healing Practice of Qigong to Teach in Los Angeles Mar. 7 & 8 2Health News:Five Leaders From Five Industries to Tackle Concerns Over the Economy and Its Impact on Compliance and Ethics During Society of Corporate Compliance and Ethics and Health Care Compliance Association Audio/Web Conference 2
... Cardiac troponin I (cTnI) has been useful ... to Emergency Departments (ED) with chest pain. ... diagnosed when blood levels of sensitive and ... MB isoenzyme of creatine kinase (CK-MB), and ...
... Aio! 2nd generation cardiac troponin ... sensitive immunoassay providing quantitative results ... less than 18 minutes. The ... unique combination of antibodies that ...
... high-throughput immunoassay system built around the many ... the important addition of Logic Driven Incubation ... designed for optimal performance with the fastest ... assays such as the cardiac biomarkers and ...
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
Medicine Products: